Literature DB >> 4957011

Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli.

R M McCune, F M Feldmann, W McDermott.   

Abstract

The capability of tubercle bacilli to assume a long continued sterile state in the tissues when exposed to pyrazinamide and isoniazid is a highly specific drug-microbe phenomenon in which host participation is not critical. Although it is the pyrazinamide that possesses the sterilizing type of action, the role of the isoniazid is specific and essential. The isoniazid serves to convert a phenomenon that occurs irregularly with pyrazinamide alone into one that occurs with a high degree of uniformity. The observations suggest a competition between isoniazid and the pyrazinamide (or its parent nicotinamide) for a site or entrance in or on the tubercle bacilli and for sterilization, the isoniazid apparently must reach the site first. The rare failures to attain complete sterilization, appear to depend on the emergence of pyrazinamide-resistance which prevents the necessary dependent action of the two drugs. Populations already in the sterile state are nevertheless subject to a continued drug influence. Whether this represents a direct action on the sterile bacilli or an indirect effect produced by making the environment hostile to microbial revival, cannot be determined from the present observations.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4957011      PMCID: PMC2138156          DOI: 10.1084/jem.123.3.469

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  FURTHER EXPERIMENTS ON LONG-TERM CHEMOTHERAPY OF ADVANCED MURINE TUBERCULOSIS, WITH EMPHASIS ON INTERMITTENT REGIMES.

Authors:  F GRUMBACH; G CANETTI; J GROSSET
Journal:  Tubercle       Date:  1964-06

2.  PRIMARY DRUG RESISTANCE IN TUBERCULOSIS.

Authors:  G CANETTI; N RIST; J GROSSET
Journal:  Am Rev Respir Dis       Date:  1964-11

3.  The influence of chemoprophylaxis on immunity in experimental tuberculosis.

Authors:  H P LAMBERT
Journal:  Am Rev Respir Dis       Date:  1960-11

4.  [Activity of pyrazinamide against experimental tuberculosis].

Authors:  F GRUMBACH
Journal:  Ann Inst Pasteur (Paris)       Date:  1958-06

5.  Ineffectiveness of isoniazid in modifying the phenomenon of microbial persistence.

Authors:  R McCUNE; S H LEE; K DEUSCHLE; W McDERMOTT
Journal:  Am Rev Tuberc       Date:  1957-12

6.  Resistance of tubercle bacilli to pyrazinamide in vivo.

Authors:  S H LEE; R M MCCUNE; W MCDERMOTT; R TOMPSETT; O WASZ-HOCKERT
Journal:  Am Rev Tuberc       Date:  1956-10

7.  Microbial persistence.

Authors:  W McDERMOTT
Journal:  Yale J Biol Med       Date:  1958-02

8.  CORYNEBACTERIAL PSEUDOTUBERCULOSIS IN MICE. I. COMPARATIVE SUSCEPTIBILITY OF MOUSE STRAINS TO EXPERIMENTAL INFECTION WITH CORYNEBACTERIUM KUTSCHERI.

Authors:  C H PIERCE-CHASE; R M FAUVE; R DUBOS
Journal:  J Exp Med       Date:  1964-08-01       Impact factor: 14.307

9.  Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.

Authors:  R M MCCUNE; R TOMPSETT
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

10.  The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug.

Authors:  R M MCCUNE; W MCDERMOTT; R TOMPSETT
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

View more
  59 in total

Review 1.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.

Authors:  Mary A De Groote; Veronica Gruppo; Lisa K Woolhiser; Ian M Orme; Janet C Gilliland; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

3.  An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis.

Authors:  Toshiko Miyata; Chan-Ick Cheigh; Nicola Casali; Amador Goodridge; Olivera Marjanovic; Lon V Kendall; Lee W Riley
Journal:  Vaccine       Date:  2011-11-08       Impact factor: 3.641

4.  Testing of experimental compounds in a relapse model of tuberculosis using granulocyte-macrophage colony-stimulating factor gene-disrupted mice.

Authors:  Lisa K Woolhiser; Donald R Hoff; Karen S Marietta; Ian M Orme; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

5.  Trans-translation mediates tolerance to multiple antibiotics and stresses in Escherichia coli.

Authors:  Jinghua Li; Lei Ji; Wanliang Shi; Jianping Xie; Ying Zhang
Journal:  J Antimicrob Chemother       Date:  2013-06-27       Impact factor: 5.790

6.  Reactivation of latent tuberculosis: variations on the Cornell murine model.

Authors:  C A Scanga; V P Mohan; H Joseph; K Yu; J Chan; J L Flynn
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.

Authors:  Sandirai Musuka; Shashikant Srivastava; Chandima Wasana Siyambalapitiyage Dona; Claudia Meek; Richard Leff; Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

8.  Guinea pig model of Mycobacterium tuberculosis latent/dormant infection.

Authors:  Suely S Kashino; Danielle R Napolitano; Ziedonis Skobe; Antonio Campos-Neto
Journal:  Microbes Infect       Date:  2008-09-06       Impact factor: 2.700

9.  The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; M De La Luz Streber; H Orozco; K Arriaga; L Pavon; S A Al-Nakhli; G A Rook
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

10.  Distinct specificities of Mycobacterium tuberculosis and mammalian proteasomes for N-acetyl tripeptide substrates.

Authors:  Gang Lin; Christopher Tsu; Lawrence Dick; Xi K Zhou; Carl Nathan
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.